Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples